Valuation: Berkley Renewables Inc.

Market Cap 364K 312K 292K 267K 502K 34.87M 508K 3.45M 1.35M 17.51M 1.37M 1.34M 57.93M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.39M 4.11M 3.76M 7.06M 490M 7.15M 48.54M 18.93M 246M 19.25M 18.83M 815M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 19/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 16/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
-0.01%+6.38%+39.36%+16.12% 162B
+0.53%+6.63%+64.41%+70.40% 106B
+0.57%+7.32%+26.37%+18.42% 80.28B
-0.36%+5.04%+33.76%-2.56% 61.28B
+1.18%+5.29%+100.13%+74.91% 60.8B
-0.14%+4.07%+47.07%+42.09% 59.01B
-0.41%+7.09%+39.65%-1.29% 56.46B
+0.51%+3.62%+26.94%-11.25% 46.03B
-1.67%-1.67%+43.24%+14.03% 35.77B
Average +0.02%+4.77%+46.77%+24.54% 66.77B
Weighted average by Cap. +0.12%+5.88%+46.85%+27.48%

Financials

2016 2017
Net sales 1.03M 886K 829K 759K 1.42M 98.94M 1.44M 9.79M 3.82M 49.7M 3.88M 3.8M 164M 1.72M 1.48M 1.38M 1.27M 2.37M 165M 2.41M 16.33M 6.37M 82.9M 6.48M 6.34M 274M
Net income 173K 148K 138K 127K 238K 16.52M 241K 1.64M 638K 8.3M 648K 634K 27.46M -631K -540K -505K -463K -868K -60.33M -880K -5.97M -2.33M -30.3M -2.37M -2.32M -100M
Net Debt 2.92M 2.5M 2.34M 2.14M 4.02M 279M 4.07M 27.62M 10.77M 140M 10.95M 10.71M 464M 4.76M 4.08M 3.82M 3.49M 6.56M 456M 6.64M 45.09M 17.58M 229M 17.88M 17.49M 757M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-